Retatrutide
Triple-G Agonist
Administration
Categories
Also Known As
LY3437943
Overview
A next-generation experimental weight-loss drug that targets three different receptors (GLP-1, GIP, and Glucagon), leading to unmatched fat reduction in clinical trials.
Safety & Considerations
Currently in Phase III trials. Similar gastrointestinal side effects to semaglutide but potentially more pronounced due to the additional glucagon agonism. Not yet approved; research use only.
Always consult a healthcare professional. This information is for educational purposes only.
Benefits
- Unprecedented weight loss (up to 24% in trials)
- Resolves fatty liver disease rapidly
- Excellent blood sugar management
How It Works
Acts as an agonist at the GLP-1, GIP, and glucagon receptors, synergistically suppressing appetite while actively increasing energy expenditure.
Common Uses
- Severe obesity
- Non-alcoholic fatty liver disease (NAFLD)
Typical Protocol
Starting at 1mg or 2mg weekly via subcutaneous injection, titrating up slowly.
Dosing information is for research reference only.
Research Status
Investigational; currently in Phase III clinical trials.
For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide or research compound.
Frequently Asked Questions About Retatrutide
What is Retatrutide used for?
Severe obesity. Non-alcoholic fatty liver disease (NAFLD).
What is the typical Retatrutide protocol?
Starting at 1mg or 2mg weekly via subcutaneous injection, titrating up slowly.
Is Retatrutide safe?
Safety rating: Use With Caution. Currently in Phase III trials. Similar gastrointestinal side effects to semaglutide but potentially more pronounced due to the additional glucagon agonism. Not yet approved; research use only.
How does Retatrutide work?
Acts as an agonist at the GLP-1, GIP, and glucagon receptors, synergistically suppressing appetite while actively increasing energy expenditure.
This information is for educational purposes only and should not be taken as medical advice. Always consult a qualified healthcare professional.
Further Reading & Research
Explore independent research and regulatory information about Retatrutide.
Part of the GLP-1 Peptide Family — Retatrutide is one of several compounds in the GLP-1 and metabolic peptide category. Compare all GLP-1 peptides →
Related Peptides
Tesamorelin
Visceral Fat Destroyer
Semaglutide
Blockbuster Weight Loss Peptide
Tirzepatide
Dual-Action Metabolic Optimizer
MOTS-c
Exercise Mimetics Peptide
